Follow-The-Filings

Security · featured owners

A Agilent Technologies Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 4 Owners
  • Max 4.8%
  • $285M
  • 1 new 1 reduce

A (Agilent Technologies Inc.) is held in 4 featured 13F books as of 2026 Q2. Glenview Capital Management is the largest tracked holder by portfolio weight (4.8%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 4.8% (Glenview Capital Management) · not free-float ownership

  1. Glenview Capital Management new 4.8%
  2. William Von Mueffling reduce 2.5%
  3. Greenhaven Associates 0.02%
  4. Ron Baron 0.01%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Glenview Capital Management 2026 Q2 4.8% New 4.8% 1,969,541 $262M history
William Von Mueffling - Cantillon Capital Management 2026 Q2 2.5% Reduce −95.4% 126,437 $17M history
Ron Baron - Bamco Inc. (Baron Capital) 2026 Q2 0.01% Hold 36,589 $5M history
Greenhaven Associates 2026 Q2 0.02% Hold 10,700 $1M history

4 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 15 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,5.02,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K/A 5.02,9.01 Filing Doc
8-K 5.01,9.01 Filing Doc
8-K 5.03,5.07,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEFA14A Filing Doc
10-K Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 13 rows shown

Filed Form Detail Links
4 Period Sep 8, 2026 Filing Doc
4 Period Sep 4, 2026 Filing Doc
4 Period Jun 26, 2026 Filing Doc
4 Period Jun 3, 2026 Filing Doc
4 Period May 29, 2026 Filing Doc
4 Period May 19, 2026 Filing Doc
4 Period May 8, 2026 Filing Doc
4 Period Mar 31, 2026 Filing Doc
4 Period Mar 19, 2026 · 10 forms Filing Doc
4 Period Feb 27, 2026 · 3 forms Filing Doc
4/A Period Nov 26, 2025 Filing Doc
4 Period Dec 1, 2025 Filing Doc
4 Period Nov 26, 2025 · 2 forms Filing Doc

Updated 5 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $6.83B $6.51B $6.95B
Net income $1.24B $1.29B $1.3B
Net margin * 18.1% 19.8% 18.8%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $4.19B $3.96B $4.59B
Total non-current assets * $6.58B $7.89B $8.13B
Total assets $10.76B $11.85B $12.73B
Total current liabilities $1.6B $1.9B $2.35B
Total non-current liabilities * $3.32B $4.05B $3.64B
Total equity $5.84B $5.9B $6.74B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.77B $1.75B $1.56B
Cash from investing -$0.31B -$1.26B -$0.394B
Cash from financing -$930M -$752M -$715M
Net change in cash $537M -$261M $459M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders